The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Perrigo Company PLC

NYSE: PRGO
Last

(U.S.) $85.89

Today's change-1.11 -1.28%
Updated November 17 4:02 PM EST. Delayed by at least 15 minutes.
 

Perrigo Company PLC

NYSE: PRGO
Last

(U.S.) $85.89

Today's change-1.11 -1.28%
Updated November 17 4:02 PM EST. Delayed by at least 15 minutes.

Perrigo Company PLC down (U.S.)$1.11

Perrigo Company PLC closed lower Friday, dropping (U.S.)$1.11 or 1.28% to (U.S.)$85.89. Shares have lost 2.06% over the last five days, but have gained 3.20% over the last year to date. This security has underperformed the S&P 500 by 20.74% during the last year.

Key company metrics

  • Open(U.S.) $86.51
  • Previous close(U.S.) $87.00
  • High(U.S.) $86.78
  • Low(U.S.) $85.80
  • Bid / Ask-- / --
  • YTD % change+3.20%
  • Volume1,188,585
  • Average volume (10-day)1,903,251
  • Average volume (1-month)1,425,033
  • Average volume (3-month)1,528,592
  • 52-week range(U.S.) $63.68 to (U.S.) $91.73
  • Beta0.66
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forward17.58×
  • Forward PEG2.44×
  • Indicated annual dividend(U.S.) $0.64
  • Dividend yield0.75%
  • Trailing EPS(U.S.) -$9.14
Updated November 17 4:02 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
-26.28%

Perrigo Company PLC has a net profit margin of -26.28%. Besides being negative, it is also below the industry average and implies that this company is not effective at turning revenues into bottom line profit.
Company Books

S&P TSX0.40%Sector:HealthcareIndustry:Pharmaceuticals - Diversified

Latest Company News

View more News
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2017Q2/2017Q1/2017Q4/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201709/30/2017Jul 01, 201707/01/2017Apr 01, 201704/01/2017Dec 31, 201612/31/2016
Revenue1,2311,2381,1941,331
Total other revenue--------
Total revenue1,2311,2381,1941,331
Gross profit498505464488
Total cost of revenue734733730844
Total operating expense1,0691,2241,0661,816
Selling / general / administrative288275282316
Research & development38434042
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)1217551615
Other operating expenses, total-3-2-36--
Operating income16214129-485
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax129-7696-1,644
Income after tax45-7072-1,359
Income tax, total84-724-285
Net income45-7072-1,359
Total adjustments to net income--------
Net income before extra. items45-7072-1,359
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items45-7072-1,359
Inc. avail. to common incl. extra. items45-7072-1,359
Diluted net income45-7072-1,359
Dilution adjustment--00--
Diluted weighted average shares142143144144
Diluted EPS excluding extraordinary itemsvalue per share0.31-0.490.50-9.46
Dividends per sharevalue per share0.160.160.160.15
Diluted normalized EPSvalue per share0.370.310.76-6.68